22:36 , Apr 4, 2018 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: March 2018

New Therapeutic Targets and Biomarkers: March 2018...
23:20 , Mar 27, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Bacterial infection Chimeric antigens against...
07:00 , Mar 31, 2016 |  BC Innovations  |  Distillery Techniques

Techniques: Bacteria-derived, sheath-like nanoparticles for antigen delivery in infectious disease vaccines

Drug delivery TECHNOLOGY: Nanoparticles Sheath-like nanoparticles derived from bacteria could be used to deliver vaccine antigens to prevent infections. The sheaths consisted of tubular, heterodimeric structures of ClpV-interacting protein A (VipA) and VipB isolated from...
07:00 , Aug 4, 2011 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information Drug platforms A recombinant Neisseria meningitidis factor H-binding protein (fHBP)-based vaccine for broad protective immunity A recombinant fHBP-based vaccine could provide protection against serogroup B N. meningitidis...
08:00 , Feb 26, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Infectious disease Meningitis Complement factor H (CFH); genome-derived neisserial antigen 1870 (GNA1870; fHbp; R2086) Structural data on CFH in complex...